Hello friends, We now find that we have a lot more to tell you all regarding bioavailability and bioequivalence. Hence we choose to continue to focus on it in the month of April also. Following is the allotment of topics. Kranthi ---------- Factors affecting Bioavailability Niklesh ---------- Biowaivers Santosh ---------- Bioequivalence from the regulatory perspective J.Vijaya Ratna - Drugs showing highly variable bioavailability We plan to present our views on the discussion of Eva Vertes: The future of Medicine. http://www.ted.com/talks/eva_vertes_looks_to_the_future_of_medicine.html